The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender and diet.
Open accessAbstract
Hepatic lipase (HL) plays a central role in LDL and HDL remodeling. High HL activity is associated with small, dense LDL particles and with reduced HDL2 cholesterol levels. HL activity is determined by an HL gene promoter polymorphism, by gender (lower in premenopausal women), and by visceral obesity with insulin resistance. The activity is affected by dietary fat intake and selected medications. There is evidence for an interaction of the HL promoter polymorphism with visceral obesity, dietary fat intake, and with lipid-lowering medications in determining the level of HL activity. The dyslipidemia with high HL activity is a potentially proatherogenic lipoprotein profile in the metabolic syndrome, in Type 2 diabetes, and in familial combined hyperlipidemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Small HDL in hypertriglyceridemia is associated with hypercatabolism of apolipoprotein A-I (47, 48), and it seems to be related to elevated hepatic lipase activity in central obesity and insulin resistance (49).”
From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [49]
Citations
Cites
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
Sex differences in the relation of visceral adipose tissue accumulation to total body fatness
Lemieux, S., Prud’homme, D., Bouchard, C., Tremblay, A., & Després, J. (1993) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/58.4.463 · Cited by 570
Heiss, G., Tamir, I., Davis, C. E., Tyroler, H. A., Rifkand, B. M., Schonfeld, G., Jacobs, D., & Frantz, I. D. (1980) · Circulation · doi:10.1161/01.cir.61.2.302 · Cited by 526
Genetic and Environmental Influences on Serum Lipid Levels in Twins
Heller, D. A., Fairé, U. D., Pedersen, N. L., Dahlén, G. H., & McClearn, G. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304223281603 · Cited by 442
Krieger, M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14011 · Cited by 402
Race, Visceral Adipose Tissue, Plasma Lipids, and Lipoprotein Lipase Activity in Men and Women
Després, J., Couillard, C., Gagnon, J., Bergeron, J., Leon, A. S., Rao, D. C., Skinner, J. S., Wilmore, J. H., & Bouchard, C. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.8.1932 · Cited by 387
McNamara, J. R., Campos, H., Ordovás, J. M., Peterson, J., Wilson, P. W. F., & Schaefer, E. J. (1987) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.7.5.483 · Cited by 383
Apolipoprotein-mediated removal of cellular cholesterol and phospholipids
Oram, J. F., & Yokoyama, S. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37453-8 · Cited by 342
Kuusi, T., Saarinen, P., & Nikkilä, E. A. (1980) · Atherosclerosis · doi:10.1016/0021-9150(80)90251-8 · Cited by 336
Alvarez, J. J., Montelongo, A., Iglesias, A., Lasunción, M. A., & Herrera, E. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37617-3 · Cited by 303
Cited by
Sorted by citations
Dyslipidemia in obesity: Mechanisms and potential targets
Klop, B., Elte, J., & Cabezas, M. (2013) · Nutrients · doi:10.3390/nu5041218 · Cited by 1,665
“This will ultimately lead to lower levels of HDL-C and a reduction in circulating HDL particles with impairment of reversed cholesterol transport [83].”
BackgroundNew Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport
Lewis, G. F., & Rader, D. J. (2005) · Circulation Research · doi:10.1161/01.res.0000170946.56981.5c · Cited by 1,104
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., Sacks, F., Murad, M. H., & Stalenhoef, A. F. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3213 · Cited by 887
“Small HDL in hypertriglyceridemia is associated with hypercatabolism of apolipoprotein A-I (47, 48), and it seems to be related to elevated hepatic lipase activity in central obesity and insulin resistance (49).”
Self-citationHigh-Density Lipoprotein Subfractions - What the Clinicians Need to Know
Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Cardiology · doi:10.1159/000346463 · Cited by 754
Causes and Metabolic Consequences of Fatty Liver
Stefan, N., Kantartzis, K., & Häring, H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0009 · Cited by 536
Metadata
- Authors
- Deeb, S. S., Zambon, A., Carr, M. C., Ayyobi, A. F., & Brunzell, J. D.
- Affiliations
- University of Washington (US)
- Corresponding author
- Deeb, Samir S.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2003-07
- Volume
- 44
- Issue
- 7
- Pages
- 1279-1286
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W2128832145
- Cited by
- 193
- References
- 80
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 8 · 2022: 6 · 2021: 5 · 2020: 4 · 2019: 5 · 2018: 12 · 2017: 4 · 2016: 6 · 2015: 9 · 2014: 9 · 2013: 7 · 2012: 8
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Heart, Lung, and Blood Institute (P01HL030086, HL3-0086, HL 64322, R01HL064322)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- hepatic lipase, dyslipidemia, visceral obesity, insulin resistance, dietary fat intake, gender differences, HDL cholesterol, small dense LDL, lipid-lowering drugs, metabolic syndrome, type 2 diabetes, familial combined hyperlipidemia, atherogenic lipoprotein profile
- MeSH terms
- Diabetes Mellitus, Type 2, Diet, Female, Haplotypes, Humans, Hyperlipidemias, Hyperlipidemia, Familial Combined, Lipase, Lipoproteins, LDL, Liver, Male, Models, Biological, Obesity, Polymorphism, Genetic, Promoter Regions, Genetic, Sex Factors, Genetic Variation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review